PMH19 ECONOMIC ASSESSMENT OF SECOND-LINE TREATMENT- SWITCHING FROM A GENERIC SSRI TO ESCITALOPRAM, AN SNRI, OR ANOTHER GENERIC SSRI BY PATIENTS WITH MAJOR DEPRESSIVE DISORDER (MDD)
Abstract
Authors
M Marynchenko AP Yu V Lauzon K Ramakrishnan EQ Wu R Ben-Hamadi MH Erder A Bose